SSA
BCYC

Schonfeld Strategic Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.8K Buy
+13,399
New +$61.4K ﹤0.01% 2368
2025
Q1 		– Sell
-42,500
Closed -$595K – 2206
2024
Q4 		$595K Sell
42,500
-380,500
-90% -$8.15M ﹤0.01% 1322
2024
Q3 		$9.57M Buy
423,000
+265,562
+169% +$6.13M 0.06% 312
2024
Q2 		$3.19M Sell
157,438
-263,362
-63% -$5.95M 0.02% 708
2024
Q1 		$10.5M Buy
420,800
+313,800
+293% +$6.67M 0.07% 360
2023
Q4 		$1.93M Buy
107,000
+54,900
+105% +$908K 0.01% 810
2023
Q3 		$1.05M Sell
52,100
-14,000
-21% -$320K 0.01% 1007
2023
Q2 		$1.69M Buy
66,100
+6,000
+10% +$139K 0.01% 803
2023
Q1 		$1.28M Sell
60,100
-19,646
-25% -$493K 0.01% 853
2022
Q4 		$2.36M Buy
79,746
+58,946
+283% +$1.58M 0.02% 759
2022
Q3 		$483K Sell
20,800
-500
-2% -$11.9K ﹤0.01% 1778
2022
Q2 		$358K Buy
21,300
+13,300
+166% +$280K ﹤0.01% 1554
2022
Q1 		$351K Buy
+8,000
New +$374K ﹤0.01% 1583
2021
Q4 		– Sell
-59,972
Closed -$2.49M – 2148
2021
Q3 		$2.49M Buy
59,972
+5,110
+9% +$179K 0.03% 641
2021
Q2 		$1.67M Buy
54,862
+43,762
+394% +$1.32M 0.02% 770
2021
Q1 		$331K Buy
+11,100
New +$286K ﹤0.01% 1298

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Schonfeld Strategic Advisors's BCYC Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 13,399 shares worth $56.8K. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in BCYC as recently as Q4 2024.

Schonfeld Strategic Advisors first reported a position in BCYC in Q1 2021 and has held it in 16 quarters since. The position peaked at $10.5M in Q1 2024. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Schonfeld Strategic Advisors held 13,399 shares of Bicycle Therapeutics worth $56.8K as of Q2 2026.
  • Bicycle Therapeutics was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2368 holding.
  • Schonfeld Strategic Advisors first reported a position in Bicycle Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Bicycle Therapeutics position peaked at $10.5M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.